
Reevaluating the Effectiveness of Common Heart Attack Medications
The REBOOT trial found that beta blockers, a standard treatment for heart attack patients for over 40 years, provide no benefit for those with uncomplicated myocardial infarction and may be risky for women, potentially leading to a change in global clinical guidelines.
